Janssen-Cilag Polska Sp. z o.o. (Poland)

Janssen-Cilag Polska Sp. z o.o. is the Polish affiliate of Janssen, the pharmaceutical division of Johnson & Johnson's Innovative Medicine segment. The company is responsible for the marketing, medical support, regulatory activities and distribution of innovative prescription medicines in Poland, and for coordinating clinical development and medical education initiatives. Its therapeutic focus includes oncology and hematology, immunology, neuroscience and psychiatry, infectious diseases and vaccines, pulmonary hypertension, cardiology and retina. Janssen-Cilag Polska collaborates with healthcare professionals, hospitals, research centers and patient organizations, supports clinical trials and engages in programs facilitating access to modern therapies through cooperation with public payers. Operating under global ethical, compliance and pharmacovigilance standards, the company positions itself as an innovation-driven partner to the healthcare system, aiming to deliver transformative therapies and develop integrated solutions including personalized medicine and digital health tools.